Revolutionizing Biomarker Analysis with High-Resolution Mass Spectrometry - Case Study with TL1A

TL1A, a critical marker in various autoimmune and inflammatory diseases, poses challenges for traditional immunoassay methods. Join IQVIA Laboratories’ upcoming webinar where industry experts explore the advantages of high-resolution mass spectrometry (HRMS) in the LC-MS bioanalysis of biomarkers, with further insight from a TL1A assay case study.

Benefits for attendees:

• Understand the establishment and use of a TL1A LC-MS method with practical adaption to biomarker measurements.
• Gain more insight into the versatility of HRMS for biomarker analysis.
• Learn how ‘context of use’ principles, combined with regulated bioanalytical guidance, can provide practical solutions for drug development research.